Gemmer Asset Management LLC Takeda Pharmaceutical CO LTD Transaction History

Gemmer Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$13.12 - $15.03 $2,191 - $2,510	-167 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$13.54 - $15.35 $1,123 - $1,274	-83 Reduced 33.2%	167 $2,000
Q4 2020 Jan 28, 2021	SELL	$15.39 - $18.97 $630 - $777	-41 Reduced 14.09%	250 $5,000
Q1 2020 May 01, 2020	BUY	$13.02 - $20.31 $2,981 - $4,650	229 Added 369.35%	291 $4,000
Q3 2019 Oct 11, 2019	BUY	$16.15 - $17.99 $1,001 - $1,115	62 New	62 $1,000

Q2 2019 Jul 18, 2019	SELL	$16.58 - $20.49 $3,199 - $3,954	-193 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$16.7 - $21.52 $3,223 - $4,153	193 New	193 $4,000
Q4 2018 Jan 18, 2019	SELL	$15.64 - $21.1 $1,767 - $2,384	-113 Closed	0 $0
Q3 2018 Oct 12, 2018	SELL	$19.54 - $21.81 $1,621 - $1,810	-83 Reduced 42.35%	113 $2,000
Q2 2018 Jul 18, 2018	BUY	$18.98 - $24.95 $1,613 - $2,120	85 Added 76.58%	196 $4,000
Q1 2018 May 11, 2018	BUY	$24.41 - $30.74 $2,709 - $3,412	111 New	111 $3,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.